Tyra Lagerberg
Postdoctoral researcher
Postdoctoral researcher in pharmacoepidemiology, studying psychiatric outcomes of medication use.
Recent publications
-
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors
Journal article
Zhu N. et al, (2022), Pharmacoepidemiology and Drug Safety, 31, 1091 - 1101
-
Reply to Ploderl and Hengartner: learning about the course of suicidal behavior but not about the effects of SSRIs.
Journal article
Lagerberg T. et al, (2022), Neuropsychopharmacology, 47
-
Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study.
Journal article
Lagerberg T. et al, (2022), Neuropsychopharmacology, 47, 817 - 823
-
Association of selective serotonin re‐uptake inhibitor (SSRI) treatment with acute substance misuse outcomes
Journal article
Virtanen S. et al, (2022), Addiction, 117, 234 - 242
-
Prediction of treatment dosage and duration from free-text prescriptions: an application to ADHD medications in the Swedish prescribed drug register
Journal article
Zhang L. et al, (2021), Evidence Based Mental Health, 24, 146 - 152